The breast cancer diagnostic pathway includes tissue biopsy, tissue processing, histopathology and, if histopathology reveals invasive cancer, biomarker analysis for three breast cancer biomarkers, including estrogen receptor, progesterone receptor and human epidermal growth factor receptor-2 status. This evidence concerns the gene ERBB2 and breast cancer.